Dianthus Therapeutics Ratios (2017-2025) | DNTH

Ratios Jun2017 Sep2017 Dec2017 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -668.20%-855.57%-1,415.40%-1,108.90%-1,594.37%-2,467.61%-1,558.58%-939.13%-1,171.96%-2,106.03%-2,526.74%-16,333.68%-9,250.00%
EBIT Margin -703.67%-910.04%-1,536.60%-1,177.60%-1,705.52%-3,041.31%-2,041.65%-1,191.84%-1,376.61%-2,406.94%-2,852.71%-18,096.89%-10,173.74%
EBITDA Margin -676.39%-861.87%-1,397.00%-1,110.20%-1,596.10%-2,467.61%-1,581.46%-945.63%-1,125.97%-2,188.16%-2,523.39%-16,477.20%-9,267.68%
Operating Margin -703.67%-910.04%-1,536.60%-1,177.60%-1,705.52%-3,041.31%-2,041.65%-1,191.84%-1,376.61%-2,406.94%-2,852.71%-18,096.89%-10,173.74%
Net Margin -668.20%-855.57%-1,415.40%-1,108.90%-1,594.37%-2,467.61%-1,558.58%-939.13%-1,171.96%-2,106.03%-2,526.74%-16,333.68%-9,250.00%
FCF Margin 1,399.91%-755.74%-2,059.60%-475.20%-1,088.42%-2,784.98%-1,713.16%-780.73%-980.29%-2,072.02%-2,377.82%-12,403.11%-7,717.17%
Efficiency
Assets Average 176.71M165.05M152.50M171.57M186.34M169.37M152.98M167.58M182.68M184.51M184.75M169.62M123.62M83.28M81.04M135.55M185.93M280.93M375.71M361.60M364.13M361.29M337.33M451.76M
Equity Average 166.00M152.72M139.83M156.78M170.54M151.36M133.30M149.66M166.24M154.88M143.43M50.46M-39.56M-47.59M-56.14M58.46M173.63M270.78M365.45M348.06M345.19M340.54M315.84M424.77M
Invested Capital -42.12M172.22M159.78M145.65M134.00M179.56M161.53M141.19M125.40M173.91M158.57M151.19M135.68M-34.75M-44.37M-50.82M-61.46M178.38M168.87M372.69M358.22M337.90M352.48M328.61M303.08M546.45M
Asset Utilization Ratio 0.050.030.020.010.010.010.020.020.010.01
Leverage & Solvency
Equity Ratio -0.770.950.920.930.910.920.910.870.870.910.910.780.77-0.21-0.53-0.61-0.780.930.940.970.970.950.940.940.930.95
Valuation
Enterprise Value -63.78M-59.95M-51.57M290.40M235.83M46.39M423.89M324.11M237.18M445.35M116.57M120.03M166.39M13.91M-68.87M-23.10M-51.57M-4.70M-9.27M-138.04M-19.61M503.37M398.86M522.60M369.97M319.52M341.75M864.00M
Market Capitalization 464.00M395.67M188.96M551.19M496.39M397.75M591.08M246.98M296.53M328.12M170.52M70.56M83.04M23.92M48.19M45.97M51.83M154.10M880.40M759.56M803.72M645.21M582.75M599.14M1,266.61M
Return Ratios
Return on Sales -9.37%-11.93%-15.23%-15.49%-13.79%-12.57%-13.55%-15.37%-23.55%-40.76%
Return on Capital Employed -0.30%-0.39%-0.45%-0.44%-0.43%-0.53%-0.63%-0.56%-0.49%-0.43%-0.50%-0.58%-0.50%-0.37%-0.27%-0.21%-0.19%-0.24%-0.29%-0.34%-0.41%-0.33%
Return on Assets -0.28%-0.35%-0.40%-0.38%-0.38%-0.45%-0.54%-0.50%-0.44%-0.38%-0.44%-0.51%-0.44%-0.32%-0.23%-0.18%-0.15%-0.19%-0.23%-0.28%-0.34%-0.28%
Return on Equity -0.29%-0.38%-0.44%-0.42%-0.41%-0.51%-0.61%-0.56%-0.48%-1.28%1.38%0.90%0.64%-0.73%-0.25%-0.18%-0.15%-0.19%-0.24%-0.29%-0.36%-0.30%